Sylvester O Eraga1 , Penaere T Osahon2, Bibiana O Mudiaga-Ojemu1, Mascot O Ogbeide1, Marvelous A Ojo1, Magnus A Iwuagwu1
1Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, University of Benin, PMB 1154, Benin City, 300001, Nigeria.; 2Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy, University of Benin, PMB 1154, Benin City, 300001, Nigeria..For correspondence:- Sylvester Eraga Email: eragaso@uniben.edu Tel: +2348030884928
Published: 28 December 2018
Citation: Eraga SO, Osahon PT, Mudiaga-Ojemu BO, Ogbeide MO, Ojo MA, Iwuagwu MA. In vitro interaction between artemether-lumefantrine and some antacids and edible clay. J Sci Pract Pharm 2018; 5(1):206-208 doi: 10.47227/jsppharm.v5i1.08
© 2018 The author(s).
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only. .
Purpose: The study investigated the in vitro interactions between artemether-lumefantrine and some antacids and edible clay. Methods: Adsorption studies using three antacids; magnesium trisilicate (MT), aluminium hydroxide (AH), magnesium hydroxide (MH) as well as edible clay (EC) were carried out. A tablet brand was evaluated for tablet properties and used to determine the effects of the adsorbents on tablet disintegration time and dissolution. Results: Adsorption followed the rank order; MT(79.98%) > MH(74.21%) > AH(70.90%) > EC(37.10%) and AH(99.90%) > MH(76.20%) > MT(73.21%) > EC(47.11%) for artemether and lumefantrine respectively. The adsorbents had no effect on tablets disintegration times. There was retardation of drug dissolution and the order was: Emtrisil®(49.58%) > MT(52.20%) > MH(58.92%) > AH(62.67%) > EC(67.42%) and Emtrisil®(59.50%) > AH(62.76%) > MH(70.20%) > MT(72.80%) > EC(80.92%) as against 93.80% as against 93.86% in 0.1N HCl for artemether and lumefantrine respectively. Conclusion: The co-administration of these antacids with artemether/lumefantrine tablets should be strongly discouraged.